Skip to main content
OpenTrials
Completed

NCT Number: NCT06456853

Comparison of AI-Generated Pain Scoring Visuals With Visual Analog Scale (VAS) for Pain Assessment

This prospective study will be conducted in surgical wards, assessing postoperative patients. Initially, patients will be evaluated using the VAS method. Subsequently, they will be shown five AI-generated images depicting different pain levels and will select the image that best represents their pain. A follow-up survey will assess the effectiveness of each method.

Using ChatGPT-4/DALL-E, images corresponding to VAS scores of 1-2, 3-4, 5-6, 7-8, and 9-10 will be created. Patients will choose the image that best describes their pain, aiming to determine if AI-supported visuals offer a more accurate alternative to VAS for pain assessment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

Istanbul, 34303, Turkey (Türkiye)

About this study

Study Objective The primary objective of this study is to compare and evaluate the effectiveness of AI-generated pain visuals in assisting patients to express their pain levels with the Visual Analog Scale (VAS). By allowing patients to more accurately depict their pain through AI-supported visuals, the study aims to enhance pain management practices in clinical settings.

Study Significance Pain management is a critical component of healthcare, directly impacting patient well-being and treatment success. The VAS is a widely used tool for subjective pain assessment but can be challenging for some patients due to its abstract nature. AI-generated visuals offer a potentially more precise and understandable way for patients to communicate their pain, potentially leading to more accurate and personalized pain assessments and management.

This study aims to measure the contribution of AI-generated pain visuals to more accurate pain assessment and to explore the potential applications of this technology. Additionally, the study seeks to understand the advantages and limitations of this approach compared to traditional methods like VAS, thereby enhancing the role of AI in pain management practices.

Expected Benefits and Risks

Expected Benefits:

Improved Pain Expression: AI-generated visuals may help patients articulate their pain more clearly, leading to better pain management in clinical settings.

Personalized Treatment Approaches: Enhanced pain expression can provide healthcare providers with opportunities to create more personalized treatment plans, especially beneficial for chronic pain patients.

Enhanced Clinical Decision-Making: The use of AI visuals may facilitate more objective and reproducible pain assessments, improving overall pain management strategies.

Potential Risks:

Misinterpretation Risk: AI-generated visuals might misinterpret patient pain in certain cases, especially if the visuals are misleading or complex.

Dependence on Technology: Over-reliance on AI tools may overlook the importance of human judgment and the subjective nature of pain assessment.

Study Design This prospective study will be conducted in surgical wards, assessing postoperative patients. Initially, patients will be evaluated using the conventional VAS method, which involves marking their pain on a 0-10 scale. Subsequently, patients will be shown five AI-generated images depicting different pain levels and asked to select the image that best represents their pain. A follow-up survey will assess which method the patients found more effective for expressing their pain.

VAS Scoring:

Patients will mark their pain level on a line ranging from 0 (no pain) to 10 (worst pain).

AI-Generated Visuals:

Using ChatGPT-4/DALL-E, images corresponding to VAS scores of 1-2, 3-4, 5-6, 7-8, and 9-10 will be created. These images will specifically depict facial expressions reflecting the respective pain levels. Patients will choose the image that best describes their pain.

This study aims to identify whether AI-supported visuals provide a more accurate and user-friendly alternative to traditional VAS scoring for pain assessment.

VAS Score Descriptions VAS Score 1-2: A middle-aged man showing signs of mild discomfort.

VAS Score 3-4: A young female athlete on a soccer field expressing moderate pain.

VAS Score 5-6: A man in a kitchen environment displaying severe pain from a cut.

VAS Score 7-8: A young male feeling severe shoulder pain.

VAS Score 9-10: A young woman experiencing intense pain.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years old and above
  • Underwent surgery for any reason
  • Consented to participate in the study and signed the informed consent form

Exclusion criteria

  • Patients under 18 years old
  • Patients who did not sign the informed consent form
  • Patients with visual impairments
  • Patients whose level of consciousness is not sufficient to complete the survey
  • Patients with a history of psychiatric disorders

Treatment and study plan

Pain assesment

Other

We will ask patients about their pain and will try to asses their pain scores. Then we will ask them to which methot is more suitable for assesment.

Primary outcomes

  1. Pain assesment

    Time frame: 10 minutes

    The primary outcome for this research is to compare the effectiveness of AI-generated pain assessment visuals with the traditional Visual Analog Scale (VAS) in accurately evaluating and expressing patients' pain levels. This will be measured through patient-reported ease of use, clarity, and usefulness of both methods, as well as patient preference for either method in pain assessment.

Sponsors and collaborators

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 13, 2024
Registry last updated
Feb 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.